egl-9 family hypoxia inducible factor 1 pseudogene 1 (EGLN1P1)

egl-9 family hypoxia inducible factor 1 pseudogene 1 (EGLN1P1) is classified as a pseudogene of the EGLN1 gene, meaning it is a segment of DNA that resembles a functional gene but is generally considered non-functional and does not encode a protein product. There is no evidence from standard references or gene databases that EGLN1P1 acts as a receptor, enzyme, transporter, or other classical therapeutic target. Its biological significance, if any, is poorly documented and not established in current genetic or pharmacological literature. It is distinct from EGLN1 (also known as PHD2), which is a protein-coding gene and a target involved in oxygen homeostasis and the hypoxia-inducible factor pathway. There are no known disease associations, drug interactions, or mechanisms of action for EGLN1P1. Note: If your interest centers on therapeutic targets, EGLN1P1 is not considered an actionable or druggable entity. The biologically significant and clinically relevant target in the EGLN family is EGLN1 (prolyl hydroxylase domain 2, PHD2), not EGLN1P1.

Other names

egl-9 family hypoxia inducible factor 1 pseudogene 1EGLN1 pseudogene 1EGLN1P1

None